HAS Authority Over Cancer Program Become Hot Issues; Fredrickson Opposes Exemption For NCI
In Brief: Cancer Claims Morris Kupchan, Who Found Promising New Antitumor Drugs In Plants
L-PAM Benefit To Post-Menopausal Patients Challenged
NCI Relates FDA Instructions On Latest IND Delays
Two Workshops To Look For New Research Areas
Proposed Regulations for Center Grants In Federal Register
Obey Attacks NCI In Campaign Speech
Trending Stories
- Imaging’s ride to the bottom in clinical trials—and why it matters now
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - In the Headlines: Is oncology ready to move away from animal testing?
- NIH says it’s moving away from animal-based models
- The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic - ODAC nixes GSK’s Blenrep myeloma regimens, citing ocular toxicity, dosing, applicability to U.S. population